These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 32687473)

  • 1. Factors Affecting the Implementation of Electronic Antiretroviral Therapy Adherence Monitoring and Associated Interventions for Routine HIV Care in Uganda: Qualitative Study.
    Haberer JE; Garrison L; Tumuhairwe JB; Baijuka R; Tindimwebwa E; Tinkamanyire J; Burns BF; Asiimwe S
    J Med Internet Res; 2020 Sep; 22(9):e18038. PubMed ID: 32687473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings.
    Haberer JE; Baijuka R; Tumuhairwe JB; Tindimwebwa EB; Tinkamanyire J; Tuhanamagyezi E; Musoke L; Garrison LE; DelSignore M; Musinguzi N; Asiimwe S
    Front Digit Health; 2022; 4():899643. PubMed ID: 35937420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic Antiretroviral Therapy Adherence Monitors and Associated Interventions Improve Adolescent-Caregiver Relationships and Self-Efficacy Among Adolescents and Young Adults with HIV in Uganda.
    Adong J; Asiimwe S; Nansera D; Muyindike W; Tumuhairwe JB; Baijuka R; Tindimwebwa E; Garrison LE; Haberer JE
    AIDS Patient Care STDS; 2023 Oct; 37(10):489-494. PubMed ID: 37862075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Habit formation in support of antiretroviral medication adherence in clinic-enrolled HIV-infected adults: a qualitative assessment using free-listing and unstructured interviewing in Kampala, Uganda.
    Jennings Mayo-Wilson L; Devoto B; Coleman J; Mukasa B; Shelton A; MacCarthy S; Saya U; Chemusto H; Linnemayr S
    AIDS Res Ther; 2020 Jun; 17(1):30. PubMed ID: 32513192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere.
    Campbell JI; Eyal N; Musiimenta A; Burns B; Natukunda S; Musinguzi N; Haberer JE
    AIDS Behav; 2018 Oct; 22(10):3363-3372. PubMed ID: 29926301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.
    MacCarthy S; Saya U; Samba C; Birungi J; Okoboi S; Linnemayr S
    BMC Public Health; 2018 Oct; 18(1):1158. PubMed ID: 30286746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study.
    Twimukye A; Bwanika Naggirinya A; Parkes-Ratanshi R; Kasirye R; Kiragga A; Castelnuovo B; Wasswa J; Nabaggala MS; Katabira E; Lamorde M; King RL
    JMIR Mhealth Uhealth; 2021 Jun; 9(6):e17418. PubMed ID: 34121665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
    Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
    BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
    Root R; Whiteside A
    J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
    Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
    AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda.
    Musiimenta A; Atukunda EC; Tumuhimbise W; Haberer JE
    AIDS Care; 2018 Aug; 30(sup5):S89-S96. PubMed ID: 30626191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda.
    Zakumumpa H; Alinaitwe A; Kyomuhendo M; Nakazibwe B
    BMC Infect Dis; 2024 Aug; 24(1):876. PubMed ID: 39198739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.
    Campbell JI; Musiimenta A; Burns B; Natukunda S; Musinguzi N; Haberer JE; Eyal N
    AIDS Care; 2019 Jun; 31(6):761-766. PubMed ID: 30606037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial.
    Musiimenta A; Atukunda EC; Tumuhimbise W; Pisarski EE; Tam M; Wyatt MA; Ware NC; Haberer JE
    JMIR Mhealth Uhealth; 2018 May; 6(5):e122. PubMed ID: 29773527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda.
    Ware NC; Pisarski EE; Tam M; Wyatt MA; Atukunda E; Musiimenta A; Bangsberg DR; Haberer JE
    AIDS; 2016 May; 30(8):1287-94. PubMed ID: 26807967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The one who doesn't take ART medication has no wealth at all and no purpose on Earth" - a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits of ART.
    Saya U; MacCarthy S; Mukasa B; Wabukala P; Lunkuse L; Wagner Z; Linnemayr S
    BMC Public Health; 2022 May; 22(1):1056. PubMed ID: 35619119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.
    Ware NC; Wyatt MA; Pisarski EE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Bangsberg DR; Haberer JE;
    AIDS Behav; 2020 Sep; 24(9):2624-2636. PubMed ID: 32140877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
    Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
    AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.